Case Report: Anti-LGI1 encephalitis during FcRn inhibition with efgartigimod for myasthenia gravis: implications for the limitations of IgG recycling blockade
ObjectivesAnti–leucine-rich glioma-inactivated 1 (LGI1) antibody–associated autoimmune encephalitis is a treatable disorder characterized by subacute cognitive impairment. Efgartigimod is a neonatal Fc receptor (FcRn) antagonist that reduces circulating IgG levels. It is approved for the treatment o...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Frontiers Media S.A.
2026-05-01
|
| Σειρά: | Frontiers in Immunology |
| Θέματα: | |
| Διαθέσιμο Online: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1854357/full |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|